Elevated Serum Resistin in Juvenile IdiopathicArthritis: Relation to Categories and Disease Activity

Background Juvenile Idiopathic Arthritis (JIA) is one of the more common chronic diseases of childhood that often persists into adulthood and can result in significant long-term morbidity, including physical disability. The aim of the present study was to assess the serum level of resistin in JIA pa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of clinical immunology 2013, Vol.33 (1), p.297-301
Hauptverfasser: Gheita, Tamer A., El-Gazzar, Iman I., El Shazly, Reem I., El-Din, Abeer M. Nour, Abdel-Rasheed, Enas, Bassyouni, Rasha H.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 301
container_issue 1
container_start_page 297
container_title Journal of clinical immunology
container_volume 33
creator Gheita, Tamer A.
El-Gazzar, Iman I.
El Shazly, Reem I.
El-Din, Abeer M. Nour
Abdel-Rasheed, Enas
Bassyouni, Rasha H.
description Background Juvenile Idiopathic Arthritis (JIA) is one of the more common chronic diseases of childhood that often persists into adulthood and can result in significant long-term morbidity, including physical disability. The aim of the present study was to assess the serum level of resistin in JIA patients and compare its levels according to the categories, clinical manifestations and disease activity. Methods Sixty-eight JIA patients and 33 age and sex matched control children were included in the present study. All patients included in this study were subjected to full history taking, clinical examination. Juvenile arthritis disease activity score in 27 joints (JADAS-27) was calculated and Childhood Health Assessment Questionnaire (CHAQ) was used to measure the functional status. Serum resistin levels were measured by enzyme-linked immunosorbent assay (ELISA). Results The mean serum resistin was significantly higher in the JIA patients (4.01 ± 2.46 ng/ml) compared to the control (2.08 ± 1.23 ng/ml) ( p  
doi_str_mv 10.1007/s10875-012-9760-6
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1278221398</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2874805571</sourcerecordid><originalsourceid>FETCH-LOGICAL-c246t-6b89eb763d70706ef935c8838ed8518aa53f8966cc1457935bc489ef4106ee913</originalsourceid><addsrcrecordid>eNp1kMtKAzEUhoMoWKsP4C7gejSXyWXclVpvFAQv65BmzrQp05mapIW-vSnjwo1w4CzO9_8HPoSuKbmlhKi7SIlWoiCUFZWSpJAnaESF4gUTFTtFI8IULSpasnN0EeOaEMIlEyNUz1rY2wQ1_oCw2-B3iD4m3-E8r7s9dL4F_FL7fmvTyrtJSKvgk4_3mWxt8n2HU4-nuWHZBw8R267GDz6CjYAnLvm9T4dLdNbYNsLV7x6jr8fZ5_S5mL89vUwn88KxUqZCLnQFCyV5rYgiEpqKC6c111BrQbW1gje6ktI5WgqVjwtX5kRT0gxDRfkY3Qy929B_7yAms-53ocsvDWVKM0Z5pTNFB8qFPsYAjdkGv7HhYCgxR5lmkGmyTHOUaWTOsCETM9stIfxp_jf0A1Apd0s</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1278221398</pqid></control><display><type>article</type><title>Elevated Serum Resistin in Juvenile IdiopathicArthritis: Relation to Categories and Disease Activity</title><source>SpringerNature Journals</source><creator>Gheita, Tamer A. ; El-Gazzar, Iman I. ; El Shazly, Reem I. ; El-Din, Abeer M. Nour ; Abdel-Rasheed, Enas ; Bassyouni, Rasha H.</creator><creatorcontrib>Gheita, Tamer A. ; El-Gazzar, Iman I. ; El Shazly, Reem I. ; El-Din, Abeer M. Nour ; Abdel-Rasheed, Enas ; Bassyouni, Rasha H.</creatorcontrib><description>Background Juvenile Idiopathic Arthritis (JIA) is one of the more common chronic diseases of childhood that often persists into adulthood and can result in significant long-term morbidity, including physical disability. The aim of the present study was to assess the serum level of resistin in JIA patients and compare its levels according to the categories, clinical manifestations and disease activity. Methods Sixty-eight JIA patients and 33 age and sex matched control children were included in the present study. All patients included in this study were subjected to full history taking, clinical examination. Juvenile arthritis disease activity score in 27 joints (JADAS-27) was calculated and Childhood Health Assessment Questionnaire (CHAQ) was used to measure the functional status. Serum resistin levels were measured by enzyme-linked immunosorbent assay (ELISA). Results The mean serum resistin was significantly higher in the JIA patients (4.01 ± 2.46 ng/ml) compared to the control (2.08 ± 1.23 ng/ml) ( p  &lt; 0.001) especially those with systemic-onset. Its level was significantly higher in those receiving steroids and those with a positive antinuclear antibody. Resistin significantly correlated with the JADAS27 (r 0.26, p 0.035) and CHAQ (r 0.4, p 0.001). The JIA patients were 50 females and 18 males; however, the level of resistin was insignificantly different according to the gender although there was a tendency to be higher in females. Conclusion Our results reinforce the proposition of an important role for resistin in JIA and may be considered an interesting biomarker for disease activity especially those with systemic onset.</description><identifier>ISSN: 0271-9142</identifier><identifier>EISSN: 1573-2592</identifier><identifier>DOI: 10.1007/s10875-012-9760-6</identifier><identifier>CODEN: JCIMDO</identifier><language>eng</language><publisher>Boston: Springer US</publisher><subject>Biomedical and Life Sciences ; Biomedicine ; Brief Communication ; Immunology ; Infectious Diseases ; Internal Medicine ; Medical Microbiology</subject><ispartof>Journal of clinical immunology, 2013, Vol.33 (1), p.297-301</ispartof><rights>Springer Science+Business Media, LLC 2012</rights><rights>Springer Science+Business Media New York 2013</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c246t-6b89eb763d70706ef935c8838ed8518aa53f8966cc1457935bc489ef4106ee913</citedby><cites>FETCH-LOGICAL-c246t-6b89eb763d70706ef935c8838ed8518aa53f8966cc1457935bc489ef4106ee913</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10875-012-9760-6$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10875-012-9760-6$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>315,781,785,27929,27930,41493,42562,51324</link.rule.ids></links><search><creatorcontrib>Gheita, Tamer A.</creatorcontrib><creatorcontrib>El-Gazzar, Iman I.</creatorcontrib><creatorcontrib>El Shazly, Reem I.</creatorcontrib><creatorcontrib>El-Din, Abeer M. Nour</creatorcontrib><creatorcontrib>Abdel-Rasheed, Enas</creatorcontrib><creatorcontrib>Bassyouni, Rasha H.</creatorcontrib><title>Elevated Serum Resistin in Juvenile IdiopathicArthritis: Relation to Categories and Disease Activity</title><title>Journal of clinical immunology</title><addtitle>J Clin Immunol</addtitle><description>Background Juvenile Idiopathic Arthritis (JIA) is one of the more common chronic diseases of childhood that often persists into adulthood and can result in significant long-term morbidity, including physical disability. The aim of the present study was to assess the serum level of resistin in JIA patients and compare its levels according to the categories, clinical manifestations and disease activity. Methods Sixty-eight JIA patients and 33 age and sex matched control children were included in the present study. All patients included in this study were subjected to full history taking, clinical examination. Juvenile arthritis disease activity score in 27 joints (JADAS-27) was calculated and Childhood Health Assessment Questionnaire (CHAQ) was used to measure the functional status. Serum resistin levels were measured by enzyme-linked immunosorbent assay (ELISA). Results The mean serum resistin was significantly higher in the JIA patients (4.01 ± 2.46 ng/ml) compared to the control (2.08 ± 1.23 ng/ml) ( p  &lt; 0.001) especially those with systemic-onset. Its level was significantly higher in those receiving steroids and those with a positive antinuclear antibody. Resistin significantly correlated with the JADAS27 (r 0.26, p 0.035) and CHAQ (r 0.4, p 0.001). The JIA patients were 50 females and 18 males; however, the level of resistin was insignificantly different according to the gender although there was a tendency to be higher in females. Conclusion Our results reinforce the proposition of an important role for resistin in JIA and may be considered an interesting biomarker for disease activity especially those with systemic onset.</description><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Brief Communication</subject><subject>Immunology</subject><subject>Infectious Diseases</subject><subject>Internal Medicine</subject><subject>Medical Microbiology</subject><issn>0271-9142</issn><issn>1573-2592</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp1kMtKAzEUhoMoWKsP4C7gejSXyWXclVpvFAQv65BmzrQp05mapIW-vSnjwo1w4CzO9_8HPoSuKbmlhKi7SIlWoiCUFZWSpJAnaESF4gUTFTtFI8IULSpasnN0EeOaEMIlEyNUz1rY2wQ1_oCw2-B3iD4m3-E8r7s9dL4F_FL7fmvTyrtJSKvgk4_3mWxt8n2HU4-nuWHZBw8R267GDz6CjYAnLvm9T4dLdNbYNsLV7x6jr8fZ5_S5mL89vUwn88KxUqZCLnQFCyV5rYgiEpqKC6c111BrQbW1gje6ktI5WgqVjwtX5kRT0gxDRfkY3Qy929B_7yAms-53ocsvDWVKM0Z5pTNFB8qFPsYAjdkGv7HhYCgxR5lmkGmyTHOUaWTOsCETM9stIfxp_jf0A1Apd0s</recordid><startdate>2013</startdate><enddate>2013</enddate><creator>Gheita, Tamer A.</creator><creator>El-Gazzar, Iman I.</creator><creator>El Shazly, Reem I.</creator><creator>El-Din, Abeer M. Nour</creator><creator>Abdel-Rasheed, Enas</creator><creator>Bassyouni, Rasha H.</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>2013</creationdate><title>Elevated Serum Resistin in Juvenile IdiopathicArthritis: Relation to Categories and Disease Activity</title><author>Gheita, Tamer A. ; El-Gazzar, Iman I. ; El Shazly, Reem I. ; El-Din, Abeer M. Nour ; Abdel-Rasheed, Enas ; Bassyouni, Rasha H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c246t-6b89eb763d70706ef935c8838ed8518aa53f8966cc1457935bc489ef4106ee913</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Brief Communication</topic><topic>Immunology</topic><topic>Infectious Diseases</topic><topic>Internal Medicine</topic><topic>Medical Microbiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gheita, Tamer A.</creatorcontrib><creatorcontrib>El-Gazzar, Iman I.</creatorcontrib><creatorcontrib>El Shazly, Reem I.</creatorcontrib><creatorcontrib>El-Din, Abeer M. Nour</creatorcontrib><creatorcontrib>Abdel-Rasheed, Enas</creatorcontrib><creatorcontrib>Bassyouni, Rasha H.</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Journal of clinical immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gheita, Tamer A.</au><au>El-Gazzar, Iman I.</au><au>El Shazly, Reem I.</au><au>El-Din, Abeer M. Nour</au><au>Abdel-Rasheed, Enas</au><au>Bassyouni, Rasha H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Elevated Serum Resistin in Juvenile IdiopathicArthritis: Relation to Categories and Disease Activity</atitle><jtitle>Journal of clinical immunology</jtitle><stitle>J Clin Immunol</stitle><date>2013</date><risdate>2013</risdate><volume>33</volume><issue>1</issue><spage>297</spage><epage>301</epage><pages>297-301</pages><issn>0271-9142</issn><eissn>1573-2592</eissn><coden>JCIMDO</coden><abstract>Background Juvenile Idiopathic Arthritis (JIA) is one of the more common chronic diseases of childhood that often persists into adulthood and can result in significant long-term morbidity, including physical disability. The aim of the present study was to assess the serum level of resistin in JIA patients and compare its levels according to the categories, clinical manifestations and disease activity. Methods Sixty-eight JIA patients and 33 age and sex matched control children were included in the present study. All patients included in this study were subjected to full history taking, clinical examination. Juvenile arthritis disease activity score in 27 joints (JADAS-27) was calculated and Childhood Health Assessment Questionnaire (CHAQ) was used to measure the functional status. Serum resistin levels were measured by enzyme-linked immunosorbent assay (ELISA). Results The mean serum resistin was significantly higher in the JIA patients (4.01 ± 2.46 ng/ml) compared to the control (2.08 ± 1.23 ng/ml) ( p  &lt; 0.001) especially those with systemic-onset. Its level was significantly higher in those receiving steroids and those with a positive antinuclear antibody. Resistin significantly correlated with the JADAS27 (r 0.26, p 0.035) and CHAQ (r 0.4, p 0.001). The JIA patients were 50 females and 18 males; however, the level of resistin was insignificantly different according to the gender although there was a tendency to be higher in females. Conclusion Our results reinforce the proposition of an important role for resistin in JIA and may be considered an interesting biomarker for disease activity especially those with systemic onset.</abstract><cop>Boston</cop><pub>Springer US</pub><doi>10.1007/s10875-012-9760-6</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0271-9142
ispartof Journal of clinical immunology, 2013, Vol.33 (1), p.297-301
issn 0271-9142
1573-2592
language eng
recordid cdi_proquest_journals_1278221398
source SpringerNature Journals
subjects Biomedical and Life Sciences
Biomedicine
Brief Communication
Immunology
Infectious Diseases
Internal Medicine
Medical Microbiology
title Elevated Serum Resistin in Juvenile IdiopathicArthritis: Relation to Categories and Disease Activity
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-13T00%3A37%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Elevated%20Serum%20Resistin%20in%20Juvenile%20IdiopathicArthritis:%20Relation%20to%20Categories%20and%20Disease%20Activity&rft.jtitle=Journal%20of%20clinical%20immunology&rft.au=Gheita,%20Tamer%20A.&rft.date=2013&rft.volume=33&rft.issue=1&rft.spage=297&rft.epage=301&rft.pages=297-301&rft.issn=0271-9142&rft.eissn=1573-2592&rft.coden=JCIMDO&rft_id=info:doi/10.1007/s10875-012-9760-6&rft_dat=%3Cproquest_cross%3E2874805571%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1278221398&rft_id=info:pmid/&rfr_iscdi=true